Results

Total Results: 518 records

Showing results for "renal".

321. Whole-Body Vibration Therapy for Osteoporosis (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/osteoporosis-vibration-therapy_technical-brief.pdf
     January 01, 2020 - can result in adverse outcomes, commonly minimal trauma atypical fractures, esophageal irritation, renal … adverse effects from bisphosphonates include minimal trauma atypical fractures, esophageal irritation, renal … smokers or past smokers within the previous 15 years; Women with current diagnosis or a history of renal … breath or chest pain Any medical condition that might affect BMD (e.g., bone cancer, end-stage renal

322. Chronic-Urinary-Retention Research (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/chronic-urinary-retention_research.pdf
     September 01, 2014 - with lower urinary tract symptoms and CUR indicate increased risk of acute urinary retention (AUR), renal … Exclusion criteria: major hematologic, renal, or hepatic impairment and major psychiatric disorders … criteria: clinical evidence of prostate cancer, infection, previous prostatic surgery, uncontrolled renal … ml Concurrent treatment: All had a 4-6-week period of indwelling catheterization to stabilize renal … <6 months, neuropathic bladder dysfunction, serum creatinine >250 mmol, abnormal upper tracts on renal

323. Layout 1 (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cad-pci-bypass_executive.pdf
     October 01, 2007 - Outcomes according to hypertension, tobacco use, renal dysfunction, and vascular disease were not generally … Other comorbidities Weak - There was no evidence suggesting that hypertension, tobacco use, renal dysfunction

324. AHRQ Slide Template 2009 (ppt file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/topic-refinement.ppt
     March 01, 2010 - What is the risk of renal dysfunction, hyperkalemia, cough, and angioedema associated with the use of … The second question is, “What is the risk of renal dysfunction, hyperkalemia, cough, and angioedema associated

325. Disposition of Comments_Technical Brief No. 40: Interventions To Decrease Hospital Length of Stay (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/hospital-length-of-stay-disposition-comments_0.pdf
     September 20, 2021 - review is that it primarily focuses on medical (non-surgical) conditions, such as diabetes, COPD, renal

326. Changing Patterns of Medication Use in Patients With Rheumatoid Arthritis in a Medicaid Population | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/rheumatoid-arthritis-medicine-1/research
     January 01, 2020 - year including solid organ transplantation, HIV/AIDS, cancer-except non-melanoma skin cancers, chronic renal

327. Horizon Scanning_Rapid Cost Analyses of Selected Potential High-Impact Intervention Reports (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/horizon-scan_research-2015.pdf
     January 01, 2015 - Depending on the success of the development pathway for some of the interventions, such as catheter-based renal … Lymphomas Intranasal Oxytocin for Social Dysfunction in Autism Spectrum Disorders Catheter-Based Renal … Catheter-Based Renal Denervation (Symplicity System) for Treatment- Resistant Hypertension The Symplicity … Assuming a 50% decrease in the need for antihypertensive medications after catheter-based renal denervation … Cell Carcinoma Pharmaceutical $180,000,000 $140,000,000 Cardiovascular Disease Catheter-Based Renal

328. Heart-Failure-Transition-Care Executive (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/heart-failure-transition-care_executive.pdf
     May 01, 2014 - readmissions within 30 days were for HF; the remainder of readmissions were for diverse indications (e.g., renal … that 35 percent of 30-day readmissions are for HF; the remainder are for diverse indications (e.g., renal … Included trials commonly excluded patients who had end-stage renal disease or severe or unstable cardiovascular

329. Medication Therapy Management | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/medication-therapy-management/research-protocol
     December 01, 2019 - criterion includes at least five of nine core chronic conditions—Alzheimer’s disease and end-stage renal … pressure; total, low-density lipoprotein, or high-density lipoprotein cholesterol; pulmonary function; renal

330. Linking Dental Services to Treatment Outcomes for Diabetes: A Rapid Response Review | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/treatment-outcomes-diabetes/rapid-research
     October 01, 2024 - risk of all-cause mortality, highlighting the impact of oral health on cardiovascular, immune, and renal

331. Hypertension-Drugs-Utilization Research (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/hypertension-drugs-utilization_research.pdf
     January 25, 2011 - Freeman, M.P.H.2,3 1 Renal Electrolyte and Hypertension Division, University of Pennsylvania School

332. Meeting Summary (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/stakeholders-engagement-others_slides-2011.pdf
     January 01, 2011 - Collyar President, Patient Advocates in Research (PAIR) Virna Elly Patient Advocate, Mid-Atlantic Renal

333. 2020 EPC Program Year in Review | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/news/2020-year-in-review
     March 01, 2021 - End-stage Renal Disease in the Medicare Population: Frequency and Duration of Hemodialysis and Quality

334. Comparative Effectiveness of Hepatitis C Treatment Adherence Interventions | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/hepatitis-c-treatment-adherence/research-protocol
     December 01, 2019 - population includes patients for whom treatment is contraindicated: Pregnant women Patients with renal … population include patients for whom treatment is contraindicated: Pregnant women Patients with renal

335. Pneumonia-Antibiotic-Treatment Executive (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/pneumonia-antibiotic-treatment_executive.pdf
     November 01, 2014 - , or antibiotic- related adverse events differ for subgroups defined by age, sex, race, ethnicity, renal … pharmacokinetic variability based on patient-specific factors such as critical illness, body weight, renal

336. Medication-Therapy-Management Research-Protocol (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/medication-therapy-management_research-protocol.pdf
     January 01, 2014 - criterion includes at least five of nine core chronic conditions—Alzheimer’s disease and end-stage renal … pressure; total, low-density lipoprotein, or high-density lipoprotein cholesterol; pulmonary function; renal

337. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/hepatitis-c-treatment-adherence_research-protocol.pdf
     September 13, 2011 - population includes patients for whom treatment is contraindicated:  Pregnant women  Patients with renal … population include patients for whom treatment is contraindicated:  Pregnant women  Patients with renal

338. Vitamin D and Calcium: A Systematic Review of Health Outcomes (Update) (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/vitamin-d-calcium_executive.pdf
     September 01, 2014 - body weight outcomes, cancer, immune function, pregnancy or birth outcomes, mortality, fracture, renal … levels, such as all-cause mortality, cancer (incidence and mortality), soft tissue calcification, renal … Renal Outcomes As described in the original report, the WHI trial (vitamin D3 400 IU in combination … with 1,000 mg calcium carbonate vs. placebo) found an increase in the risk of renal stones. … diarrhea, or upset stomach), musculoskeletal soreness, primary hyperparathyroidism, hypercalcemia, and renal

339. Integrated Pain Management Programs | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/integrated-pain-management/protocol
     December 01, 2020 - citations that have not been peer-reviewed Abbreviations: ED = emergency department; ESDR = end stage renal … 2019 CQ Contextual Question ED Emergency department EPC Evidence Based Practice Center ESDR End stage renal

340. Pharmacotherapy for Adults With Alcohol Use Disorder in Outpatient Settings: Systematic Review | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/alcohol-use-disorders/research
     May 01, 2024 - Acamprosate is contraindicated for people with severe renal impairment and requires dose adjustments … for moderate renal impairment.